UK markets closed

Sanofi (SAN.PA)

Paris - Paris Delayed price. Currency in EUR
Add to watchlist
85.01-1.64 (-1.89%)
At close: 5:35PM CET
Full screen
Previous close86.65
Open85.27
Bid0.00 x 0
Ask0.00 x 0
Day's range84.28 - 86.29
52-week range74.92 - 91.14
Volume3,118,500
Avg. volume1,758,448
Market cap106.706B
Beta (5Y monthly)0.43
PE ratio (TTM)17.35
EPS (TTM)4.90
Earnings date04 Feb 2022
Forward dividend & yield3.20 (3.69%)
Ex-dividend date05 May 2021
1y target est102.56
  • Reuters

    Baidu in partnership with Sanofi to use its algorithm in mRNA vaccine, therapy development

    Chinese tech giant Baidu Inc said on Monday it has licensed its algorithm for messenger RNA (mRNA) sequence to Sanofi SA for use in designing vaccine and therapeutic products, entering its first such commercial deal with a major global drugmaker. Sanofi had been one of the world's biggest vaccine makers before the pandemic, but the French firm was beaten by rivals BioNTech/Pfizer and Moderna in developing mRNA shots against COVID-19. Sanofi stopped trials of its own mRNA COVID-19 shot in September, and is instead focusing on efforts with GlaxoSmithKline to bring another COVID-19 vaccine candidate to market based on the more conventional protein-based approach.

  • Zacks

    Mirati (MRTX) to Begin Clinical Study in MTAP-Deleted Cancers

    Mirati (MRTX) submits an investigational new drug application to the FDA for MRTX1719 for the treatment of methylthioadenosine phosphoylase-deleted cancers.

  • Motley Fool

    These 3 High-Yield Dividend Stocks Are Growing at Blazing Speeds

    Actually, investors can have their cake and eat it too, balancing current income with principal appreciation.